Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
300
Trial Sponsor
Clinical Trial Start Date
October 31, 2017
0Primary Completion Date
May 31, 2018
0Study Completion Date
October 31, 2018
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
BCD-1350
Interventional Trial Phase
Phase 10
Official Name
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-135 (JSC BIOCAD, Russia) in Patients With Advanced Solid Tumors0
Last Updated
March 13, 2018
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-135 (JSC BIOCAD, Russia) in Patients with Advanced Solid Tumors
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
